Abstract

Nimesulide (NIM, N-(4-nitro-2-phenoxyphenyl)methanesulfonamide) is a relatively new nonsteroidal anti-inflammatory analgesic drug. It is practically insoluble in water (<0.02 mg/mL). This very poor aqueous solubility of the drug may lead to low bioavailability. The objective of the present study was to investigate the possibility of improving the solubility and the bioavailability of NIM via complexation with polysaccharide arabinogalactan (AG), disodium salt of glycyrrhizic acid (Na2GA), hydroxypropyl-β-cyclodextrin (HP-β-CD) and MgCO3. Solid dispersions (SD) have been prepared using a mechanochemical technique. The physical properties of nimesulide SD in solid state were characterized by differential scanning calorimetry and X-ray diffraction studies. The characteristics of the water solutions which form from the obtained solid dispersions were analyzed by reverse phase and gel permeation HPLC. It was shown that solubility increases for all complexes under investigation. These phenomena are obliged by complexation with auxiliary substances, which was shown by 1H-NMR relaxation methods. The parallel artificial membrane permeability assay (PAMPA) was used for predicting passive intestinal absorption. Results showed that mechanochemically obtained complexes with polysaccharide AG, Na2GA, and HP-β-CD enhanced permeation of NIM across an artificial membrane compared to that of the pure NIM. The complexes were examined for anti-inflammatory activity on a model of histamine edema. The substances were administered per os to CD-1 mice. As a result, it was found that all investigated complexes dose-dependently reduce the degree of inflammation. The best results were obtained for the complexes of NIM with Na2GA and HP-β-CD. In noted case the inflammation can be diminished up to 2-fold at equal doses of NIM.

Highlights

  • Nimesulide (NIM, Figure 1) is a non-steroidal anti-inflammatory drug (NSAID) from the sulfonamides class

  • The Differential Scanning Calorimetry (DSC) curves of free NIM exhibited endothermic peaks around 143.5 ◦C with melting heat (MH) value of 109.9 J/g, which corresponded to its intrinsic melting points (MP) of NIM active pharmaceutical substance (API) and suggested its crystalline structure as far as relatively thing reflexes in RFA diffractograms

  • In this study we investigated for the first time the possibility of improving the solubility and the bioavailability of NIM by preparing solid dispersions with HP-β-CD, polysaccharide arabinogalactan, disodium salt of glycyrrhizic acid and MgCO3 using onestep solid state mechanochemical technology

Read more

Summary

Introduction

Nimesulide (NIM, Figure 1) is a non-steroidal anti-inflammatory drug (NSAID) from the sulfonamides class. Its approved indications are treatment of acute pain, symptomatic treatment of osteoarthritis, and primary dysmenorrhea in adults and adolescents over 12 years of age. CAondceecnretraasteioinn tohfepcroonstcaegnltarnadtiionnEo2flpearodsstatoglaanddecinreEas2elienadthsetodeagdreeecroefaascetiivnatthioendoefgpreroesotafnaocitdivEaPti-otnypoef prercoesptatonrosi,dwEhPic-htyipseexrpecreespsteodrsi,nwanhaiclghesisiceaxnpdreasnsteid-iniflnamanmalagteosriyc eafnfedctas.nti-inflammatory effectIsn. terms of gastrointestinal safety, NIM is comparable to other NSAIDs. Due to c(dsmTcFnltiSotooievehapnonnaeCeerrlaccdtrtaeOhEiieeINnnndfnrrucXdo,gnanaIarM-rm,nsstFos2teBlediaprairaniesbevbnmegbllateoeogaahehotlsrunnifomieucubttdnsootprmienteg,tmfahhntoves,nBheagtrpeeI.steesrradrroapmelTeis[rgsrllt1tehfaakihilaro–dsuinneocevkr3omdoitte]EnfIsolv,.Iro.,ihtuaviecofTdgeIrnlestrophaaihhdtrelsipmaiaeelnssttatenprhraoancoacaaNletganfdeontenoUsSd,xsdaptApicrnhaoafchuoleniaIixtatagmtDtapdieynyrscbd,spmpt,,ia,NtsteaaShyNsa.ancrItee,scTecMaIoaoMswdNthUesvhrhiseIdtinsolM)ogaliii.wiltsnsicttLlaoealgasbchestdinneovhttamaheocmeesShsnearrottapttbhaprbNdhpateeNeraearpreoSncebsatInebAaaeM)nibn.losbeIledbepeDLadmcasaahsiassnytvieosau,onsneflrcassirmesaaltoeshietdnfvstploavtwheeecwmlreieerreoenraarsuolabdssldlrttslaNtaieaeetchcmthrmsvooSaactrueaAliamtdsenrgnsceIeNagoelecDtaalrsarIdtctsiseMnrhceoosa.eosifcmyafialDua(secsntcSpsneamauadepaavutdetsrfearitestioehnireeoettndnooeetssrf,. Lsiyvsetredmam[4a–g6e] aconmd pisarcehdartaocCteOriXz-e2dinbhyibloitworws [a1t–e3r].solubility (~0.02 g/L), which slows its releaNseIMfrombesloolnidgsortaol dtohseagIeI focrlmasss, tohfusdsrluowgsi,ngacthcoeradbinsogrpttoionthoef itbsiodpohsaagrme afrcoemutitchael cglaasstsriofiincatetisotinnsayl strteamct i[n4t–o6]thaenbdloisocdhsatrreaacmte.riTzheids bcryelaotews wpraetreerqsuoisluitbeisliftoyr(t~h0e.u02segi/nL)m, wedhiiccahl splroawctsicietsorfeelexacseessfirvoemdsooslaigdeosroafl ndiomsaegsuelfiodremasn,dthtuhes solcocwurinregntcheeoafbtshoerpabtioovneoufnitdsedsiorsaabglee fsriodme etfhfeecgtsa.strointestinal tract into the bloodstream. This creates prerequisites for the use in meIndiocaulrporpaicntiicoen,oftheexciemsspirvoevdemoseangtesofoNf nIMim’sesbuiloidaveaainladbitlhiteyobcycuirnrcernecaesionfgthites awbaotveer usonlduebsiilriatyblaensdidaecceeffleecrtast.ing absorption will promote the dose reduction along with high pharmInacooulrogoipcainl ieofnfe,ctthpereimseprvroatvioemn [e7n]t. Ionf oNuIrMp’rsevbiioouasvastiuladbiielsity[8–b1y2]inwcerehaasdinsghiotws nwtahteart sthoeluubsilaitgye aonfdsuacchcesleurpartianmgoalebcsuorlaprtidoneliwveilrlypsryosmteomtestihseadsousceceresdsfuucltitoonreadlouncge wthiethdhoisgehs panhdarmtoaxcicoiltoygoicfasleevfeferactl optrheesrerdvrautigosn. [A7]d.dIintioonuarllpyr, ewvieoushsosutulddineoste[8, –t1h2a]t wsoemheaadusxhiloiawryn tshuabtsttahneceussaugseedo,f nsaumchelsyupporalymsoaclecchualrairdedeAliGvearyndsygsltyecmyrsrhisizaicsauccicdes(safsulfatroarseditus csealtths)e, dpoossseesssanhdeptaotoxipcriotytecotfivseeavcetriavlityotihtseerlfd[r1u3g,1s4.].we should note, that some auxilTiahreyrseuabrsetamncaensyuasretdic,lensamdeevlyotpeodlytosaicncchraeraisdiengAGof aNnIdMg’lsycsoylrurhbiizliitcy,acfoidr (eaxsafmarpales bitys suaslitnsg),βp-ocsyscelsosdhexetprainto, phryodtreocxtiyvperoapctyivl-iβty-ciytscelolfd[e1x3t,r1in4](.HP-β-CD), [15,16,17] dendrimers, phosphatiTdhyelrcehoalrienem[a1n8,y19a]rtaincldessodleidvodtiesdpetrosionncrsewasiitnhgPoVfPN, PIMEG’s[s2o0l,u21b]i.liTtyh,efoprreepxaarmatpiolenboyf uNsIiMngcoβm-cpylcelxoedsexwtritihn,mheytadlrsoZxnyp(IrIo),pCyul-(βII-)c,yFcelo(IdIIe)xatrnidn S(bH(IPII-)βw-CeDre),al[s1o5–d1e7s]cridbeendd[r2im2]e. rIsn, pmhoosstpchaasteisdyolnclhyolsionleub[il1i8ty,19a]ndadnidssosloultiidondaissppeecrtssioannsd swoimthe iPnVvPit,roPeExGper[i2m0e,2n1t]s. wTehre pruebplaisrhaetido.nAonf iNnIcMreacsoeminpltehxeesanwtii-tihnflmametamlsatZonry(IIa)c, tCivuit(yII)o,fFNe(IIMII)bayncdomSbp(IlIeIx)awtioernewailtsho dmeestchryibl-eβd-c[y22cl]o. dInexmtrionsthcaassbeeseonnslhyoswonluibnil[i2ty3]a. nUdnfdoirstsuonluatieolyn, maseptehcytls-βa-ncdycslomdeextirninvhitaros evxepryerliimmeintetds wuseereinpupbhlaisrhmeadc.yAdnuientcoreiatsehiinghthceosatnatin-idnfnlaomt malwataoyrys dacetsiivriatbyleofabNiIliMty btoy ceoxmtrapcltexchatoiolenstewroitlhfrommetcheylll-mβe-cmycblroadneexst.rTinhehaabsovbeeerensesahrcohwenrs uinsed[2v3a].rioUunsftoercthuniaqteuleys, mfoertohbytla-βin-cinygclocodmexptrleinxehsaasnvdesroylildimditsepderussioenisn—pdhrayrmanadcywdetubeatlol mitisllihnig,hkcnoesatdainngd annodt liquid-phase synthesis

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call